BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 339 filers reported holding BIO-TECHNE CORP in Q2 2018. The put-call ratio across all filers is 3.84 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $191,306 | +16.9% | 2,670 | +14.9% | 0.00% | +33.3% |
| Q1 2024 | $163,586 | -7.7% | 2,324 | +1.2% | 0.00% | -25.0% |
| Q4 2023 | $177,159 | +40.6% | 2,296 | +24.0% | 0.00% | +33.3% |
| Q3 2023 | $125,998 | -42.5% | 1,851 | -31.0% | 0.00% | -50.0% |
| Q2 2023 | $219,095 | +33.7% | 2,684 | +21.5% | 0.01% | +50.0% |
| Q1 2023 | $163,886 | -3.5% | 2,209 | +7.8% | 0.00% | -20.0% |
| Q4 2022 | $169,904 | +54.5% | 2,050 | +427.0% | 0.01% | +25.0% |
| Q3 2022 | $110,000 | -14.1% | 389 | +5.4% | 0.00% | 0.0% |
| Q2 2022 | $128,000 | -29.7% | 369 | -12.4% | 0.00% | -20.0% |
| Q1 2022 | $182,000 | -16.1% | 421 | +0.2% | 0.01% | -28.6% |
| Q4 2021 | $217,000 | -0.9% | 420 | -7.1% | 0.01% | -12.5% |
| Q3 2021 | $219,000 | +49.0% | 452 | +38.2% | 0.01% | +33.3% |
| Q2 2021 | $147,000 | +26.7% | 327 | +7.6% | 0.01% | +20.0% |
| Q1 2021 | $116,000 | +34.9% | 304 | +12.2% | 0.01% | +25.0% |
| Q4 2020 | $86,000 | +36.5% | 271 | +6.7% | 0.00% | +33.3% |
| Q3 2020 | $63,000 | -4.5% | 254 | +2.0% | 0.00% | -25.0% |
| Q2 2020 | $66,000 | +65.0% | 249 | +19.1% | 0.00% | +33.3% |
| Q1 2020 | $40,000 | +5.3% | 209 | +22.2% | 0.00% | 0.0% |
| Q4 2019 | $38,000 | +15.2% | 171 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $33,000 | -5.7% | 171 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $35,000 | +6.1% | 169 | +3.0% | 0.00% | 0.0% |
| Q1 2019 | $33,000 | +32.0% | 164 | -6.3% | 0.00% | +50.0% |
| Q4 2018 | $25,000 | -41.9% | 175 | -16.3% | 0.00% | -50.0% |
| Q3 2018 | $43,000 | +38.7% | 209 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $31,000 | -3.1% | 209 | 0.0% | 0.00% | -25.0% |
| Q1 2018 | $32,000 | +1500.0% | 209 | +1061.1% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 18 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fithian, LLC | 101,020 | $7,494,674 | 15.66% |
| Montanaro Asset Management Ltd | 387,800 | $28,770,882 | 4.47% |
| Brown Capital Management | 3,262,377 | $242,035,750 | 3.62% |
| Sandhill Capital Partners LLC | 501,059 | $37,173,549 | 3.56% |
| STONE RUN CAPITAL, LLC | 89,435 | $6,635,183 | 3.17% |
| DF DENT & CO INC | 2,949,044 | $218,789,610 | 3.08% |
| Ownership Capital B.V. | 2,324,358 | $172,444,120 | 3.03% |
| Jackson Square Partners, LLC | 1,485,067 | $110,177,121 | 2.98% |
| Summit Creek Advisors LLC | 283,412 | $21,026,336 | 2.74% |
| Westwind Capital | 111,666 | $8,284,501 | 2.65% |